ArticleBMJ open2020

Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity.

Michaeline McGuinty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.